Articles by Disease (Rhabdomyosarcoma)

Mitochondrial Therapeutics for Cardioprotection

Journal: Current Pharmaceutical Design
Volume: 17
Page: 2017-2035
Author(s): Raquel S. Carreira, Pamela Lee and Roberta A. Gottlieb

Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence

Journal: Current Pharmaceutical Design
Volume: 17
Page: 2278-2289
Author(s): Shin-Wei Wang, Jiag-Ki Lee, Chia-Chen Ku, Shyh-Shin Chiou, Chen-Lung Steve Lin, Ming-Feng Ho, Deng-Chyang Wu and Kazunari K. Yokoyama

STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment

Journal: Current Medicinal Chemistry
Volume: 18
Page: 2359-2375
Author(s): A. Lavecchia, C. Di Giovanni and E. Novellino

Repressing the Activity of Protein Kinase CK2 Releases Mitochondria-Mediated Apoptosis in Cancer Cells

Journal: Current Drug Targets
Volume: 12
Page: 902-908
Author(s): Ismail Muhamad Hanif and Shazib Pervaiz

Drug Resistance: Challenges to Effective Therapy

Journal: Current Cancer Drug Targets
Volume: 11
Page: 613-623
Author(s): M. P.V. Shekhar

Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets

Journal: Current Drug Targets
Volume: 12
Page: 1056-1081
Author(s): Karolina Blajecka, Anna Borgstrom and Alexandre Arcaro

mTOR Inhibitors: Facing New Challenges Ahead

Journal: Current Medicinal Chemistry
Volume: 18
Page: 2743-2762
Author(s): I. Mavrommati and T. Maffucci

Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18
Page: 2854-2866
Author(s): D. Cirillo, F. Pentimalli and A. Giordano

The Urokinase Receptor Interactome

Journal: Current Pharmaceutical Design
Volume: 17
Page: 1874-1889
Author(s): Gabriele Eden, Marco Archinti, Federico Furlan, Ronan Murphy and Bernard Degryse

The ALK Gene, An Attractive Target for Inhibitor Development

Journal: Current Topics in Medicinal Chemistry
Volume: 11
Page: 1406-1419
Author(s): Carmen J. Tartari, Leonardo Scapozza and Carlo Gambacorti-Passerini